Clinical features and risk factors of mortality for bacteremia due to community-onset healthcare-associated methicillin-resistant S. aureus

Diagnostic Microbiology and Infectious Disease

Volumn 76, Issue 1, 2013, Pages 86-92

  Lee, Sai Cheong ^a   Lee, Chao Wei ^b   Shih, Hsiang Ju ^a   Chiou, Meng Jiun ^c   See, Lai Chu ^a,c   Siu, L K ^d  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Community onset; Healthcare associated MRSA bacteremia; Mortality; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; CEFOXITIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; OXACILLIN; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; AGGLUTINATION TEST; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CENTRAL VENOUS CATHETER; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; COMMUNICABLE DISEASE; COMMUNITY ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; COMMUNITY ONSET HEALTHCARE ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; CONTROLLED STUDY; DIALYSIS; DISEASE COURSE; DISK DIFFUSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIAL TYPING TECHNIQUES; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROTOXINS; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXACILLIN; PROSPECTIVE STUDIES; RISK FACTORS; SUPERANTIGENS;

EID: 84876717011     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.01.017     Document Type: Article

References (34)

1. Bannerman T.L. Staphylococcus, Micrococcus, and other catalase-positive cocci that grow aerobically. Manual of clinical microbiology 2003, 384-404. American Society of Microbiology Press, Washington, DC. 8th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.A. Pfaller, R.H. Yolken (Eds.).
2. Chen F.J., Lauderdale T.L., Huang I.W., Lo H.J., Lai J.F., Wang H.Y., et al. Methicillin-resistant Staphylococcus aureus in Taiwan. Emerg Infect Dis 2005, 11:1760-1763.
3. Chen C.J., Huang Y.C., Chiu C.H., Su L.H., Lin T.Y. Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Pediatr Infect Dis J 2005, 24:40-45.
4. Chi C.Y., Wong W.W., Fung C.P., Yu K.W., Liu C.Y. Epidemiology of community-acquired Staphylococcus aureus bacteremia. J Microbiol Immunol Infect 2004, 37:16-23.
5. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. Approved standards (M100-S19). Wayne, PA: CLSI; 2009.
6. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36:53-59.
7. Cosgrove S.E., Qi Y., Kaye K.S., Harbarth S., Karchmer A.W., Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005, 26:166-174.
8. Dinges M.M., Orwin P.M. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000, 13:16-34.
9. Enright M.C., Day N.P.J., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000, 38:1008-1015.
10. Francis J.S., Doherty M.C., Lopatin U., Johnston C.P., Sinha G., Ross T., et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005, 40:100-107.
11. Henegariu O., Heerema N.A., Dlouhy S.R., Vance G.H., Vogt P.H. Multiplex PCR: critical parameters and step-by-step protocol. Bio Tech 1997, 23:504-511.
12. Jarvis W.R., Schlosser J., Chinn R.Y., Tweeten S., Jackson M. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. Am J Infect Control 2007, 35:631-637.
13. Kallen A.J., Mu Y., Bulens S., Reingold A., Petit S., Gershman K., et al. Health care-associated invasive MRSA infections, 2005-2008. J Am Med Assoc 2010, 304:641-647.
14. Kaplan S.L., Hulten K.G., Gonzalez B.E., Hammerman W.A., Lamberth L., Versalovic J., et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005, 40:1785-1791.
15. Karasa J.A., Enoch D.A., Emery M.M. Community-onset healthcare-associated MRSA bacteraemia in a district general hospital. J Hosp Infect 2006, 62:480-486.
16. King M.D., Humphrey B.J., Wang Y.F., Kourbatova E.V., Ray S.M., Blumberg H.M. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006, 144:309-317.
17. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. J Am Med Assoc 2007, 298:1763-1771.
18. Knaus W.A., Wagner D.P., Draper E.A., Zimmerman J.E., Bergner M., Bastos P.G., et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991, 100:1619-1636.
19. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler V.G., Ryan T., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
20. Lina G., Piémont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
21. Millar B.C., Loughrey A., Elborn J.S., Moore J.E. Proposed definitions of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect 2007, 67:109-113.
22. Miller L.G., Perdreau-Remington F., Rieg G., Mehdi S., Perlroth J., Bayer A.S., et al. Necrotizing fasciitis caused by community- associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005, 352:1445-1453.
23. Murray R.J., Lim T.T., Pearson J.C., Grubb W.B., Lum G.D. Community-onset methicillin-resistant Staphylococcus aureus bacteremia in northern Australia. Int J Infect Dis 2004, 8:275-283.
24. Naimi T.S., LeDell K.H., Boxrud D.J., Groom A.V., Steward C.D., Johnson S.K., et al. Epidemiology and clonality of community-acquired methicillin -resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 2001, 23:990-996.
25. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J., et al. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. J Am Med Assoc 2003, 290:2976-2984.
26. Oliveira D.C., de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002, 46:2155-2161.
27. Panton P.N., Valentine F.C.O. Staphylococcal toxin. Lancet 1932, 1:506-508.
28. Shukla S.J. Community-associated methicillin-resistant Staphylococcus aureus and its emerging virulence. Clin Med Res 2005, 3:57-60.
29. Shurland S., Zhan M., Bradham D.D., Roghmann M.C. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 2007, 28:273-279.
30. Stevens D.L., Bisno A.L., Chambers H.F., Everett E.D., Dellinger P., Goldstein E.J., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005, 41:1373-1406.
31. Susan, Boyle-Vavra S., Ereshefsky B., Wang C.C., Daum R.S. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel staphylococcal chromosome cassette mec (SCCmec) type V T or SCCmec type IV. J Clin Microbiol 2005, 43:4719-4730.
32. Wang J.T., Chen Y.C., Yang T.L., Chang S.C. Molecular epidemiology and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in Taiwan. Diagn Microbiol Infect Dis 2002, 42:199-203.
33. Wang C.C., Lo W.T., Chu M.L., Siu L.K. Epidemiological typing of community-acquired methicillin- resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis 2004, 39:481-487.
34. Wang J.L., Chen S.Y., Wang J.T., Wu H.M., Chiang W.C., Hsueh P.R., et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community- acquired methicillin-resistant Staphylococcus aureusand methicillin-susceptible S. aureus. Clin Infect Dis 2008, 46:799-806.